Experience

AP2, Andra AP-fonden

• Sweden
• Capital Markets
• 1 - 100 Employee

• Quantitative Portfolio Manager

  • May 2007 - Present

  My work at AP2 is primarily focused on research and development of quantiative alpha- and risk models. Currently I'm mostly involved in modelling global equities with broad experience of: - Research and backtesting of new alpha strategies. - Construction of factor driven prediction models. - Construction of factor driven risk models. My work at AP2 is primarily focused on research and development of quantiative alpha- and risk models. Currently I'm mostly involved in modelling global equities with broad experience of: - Research and backtesting of new alpha strategies. - Construction of factor driven prediction models. - Construction of factor driven risk models.



AstraZeneca R&D

• Global Project Statistician

  • Jun 1995 - Apr 2007

  At AZ I spent approximately 6 years to support preclinical R&D with statistical expertise and 6 years within clinical R&D as a Global Product Statistician. I have from this time a broad experience of drug development, from early pre clinical research to design and analysis of phase III studies. At AZ I spent approximately 6 years to support preclinical R&D with statistical expertise and 6 years within clinical R&D as a Global Product Statistician. I have from this time a broad experience of drug development, from early pre clinical research to design and analysis of phase III studies.